Teva Settles Drug Patent Row With Celgene, Astellas
Teva Pharmaceuticals has settled allegations that its planned generic version of lymphoma drug Istodax would infringe patents held by Celgene Corp. and Astellas Pharma Inc., according to a joint filing by...To view the full article, register now.
Already a subscriber? Click here to view full article